ADVISORY, Dec. 4, 2008 (GLOBE NEWSWIRE) --
What: NASDAQ OMX Group (NasdaqGS:NDAQ - News), the world's largest exchange company, and Leerink Swann, the leading healthcare investment banking firm, will co-host a one-day conference, The NASDAQ OMX HealthCare Industry Forum, exploring "The Intersection of Healthcare and the Capital Markets." In addition, there will be a NASDAQ Closing Bell ceremony with AIDS spokesperson Dayana Mendoza, Miss Universe 2008; Jeffrey Leerink, Chairman and Chief Executive Officer of Leerink Swann; and Bruce Aust, Executive Vice President of NASDAQ OMX. The NASDAQ OMX HealthCare Forum will cover: * The Intersection of Healthcare and the Capital Markets: How they need each other; * The Healthcare IT Opportunity: What's real and what's yet to be harnessed?; * Public on NASDAQ: Lessons learned in building a sustainable public life sciences company; * Guidelines to a Successful Clinical and Regulatory Strategy: The pitfalls and opportunities ahead; * Healthcare Reform: Changes in a new political environment; * Partnering and M&A Drivers: What gets Big Pharma excited and how do they search for value in their acquisition strategies?; * Alternatives for Creating Value in a Challenging Time To see the detailed agenda please go to:
http://www.magnetmail.net/images/clients/NASDAQ/attach/HealthcareForumAgenda1117.pdf
Who: * Companies participating include AllscriptsMisys Healthcare
Solutions, Inc. (NasdaqGS:MDRX - News); Anadys Pharmaceuticals, Inc.
(NasdaqGM:ANDS - News); Henry Schein (NasdaqGS:HSIC - News); iCad, Inc.
(NasdaqCM:ICAD - News); ImClone Systems Incorporated (IMCL); Javelin
Pharmaceuticals, Inc. (AMEX:JAV - News); The Medicines Company
(NasdaqGS:MDCO - News); Merck & Co., Inc. (NYSE:MRK - News); Osiris
Therapeutics, Inc. (NasdaqGM:OSIR - News); and Phase Forward Incorporated
(NasdaqGM:PFWD - News).
* Industry experts from Leerink Swann & Company; Boston HC
Partners; Boston Millenia Partners; The McManus Group;
OrbiMed Advisors, LLC; Pappas Ventures; Pharmaceutical
Research and Manufacturers of America; Symphony Capital
LLC; TM Partners; University of South Florida Health.
When: Monday, December 8th, 2008 at 9:00 a.m. - 4:15 p.m. ET
Schedule:
9:00 - 9:30 a.m. Registration - NASDAQ OMX HealthCare
Industry Forum
9:30 - 9:45 a.m. NASDAQ OMX Introduction
9:45 - 3:00 p.m. Panel Discussions & Keynotes
3:00 - 3:30 p.m. Closing Remarks & Break
3:30 - 4:15 p.m. Closing Bell Ceremony
Where: NASDAQ MarketSite
4 Times Square (Corner of 43rd and Broadway)
New York, NY
RSVP: Interested parties should RSVP to Robert Madden at either
(645) 441-5045 or Robert.Madden@NASDAQOMX.com
Feed Information:
The Closing Bell is available from 3:45 p.m. to 4:05 p.m. on AMC-3/C-
3 (ul 5985V; dl 3760H). The feed can also be found on Ascent fiber
1623. If you have any questions, please contact Robert Madden at
(646) 441-5045.
Radio Feed:
An audio transmission of the Closing Bell is also available from 3:45
p.m. to 4:05 p.m. on uplink IA6 C band / transponder 24, downlink
frequency 4180 horizontal. The feed can be found on Ascent fiber 1623
as well.
Webcast:
A live webcast of the conference will be available at:
A live webcast of the NASDAQ Closing Bell will be available at: http://www.nasdaq.com/about/marketsitetowervideo.asx Photos: To obtain a hi-resolution photograph of the Market Close, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market close of your choice.
About Leerink Swann:
Leerink Swann is a healthcare-focused investment banking firm that provides equity research, corporate finance, strategic advisory, and asset management services for institutional, life sciences and high-net-worth clients. Every year since 2001, Institutional Investor has named Leerink Swann ``Best of the Boutiques'' in several healthcare categories. Through its MEDACorp division, Leerink Swann provides biomedical-consulting services to the institutional investment community. With an internal team of experts and a dedicated external network of academic and community healthcare professionals, MEDACorp assesses the viability of cutting-edge medical technologies, thus giving decision makers the information they need to perform. Leerink Swann is a member of FINRA/SIPC. For more information, visit http://www.leerink.com.
About NASDAQ OMX:
The NASDAQ OMX Group, Inc. is the world's largest exchange company. It delivers trading, exchange technology and public company services across six continents, and with over 3,900 companies, it is number one in worldwide listings among major markets. NASDAQ OMX offers multiple capital raising solutions to companies around the globe, including its U.S. listings market; the OMX Nordic Exchange, including First North; and the 144A PORTAL Market. The company offers trading across multiple asset classes including equities, derivatives, debt, commodities, structured products and ETFs. NASDAQ OMX technology supports the operations of over 60 exchanges, clearing organizations and central securities depositories in more than 50 countries. OMX Nordic Exchange is not a legal entity but describes the common offering from NASDAQ OMX exchanges in Helsinki, Copenhagen, Stockholm, Iceland, Tallinn, Riga, and Vilnius. For more information about NASDAQ OMX, visit http://www.nasdaqomx.com/.
NDAQM
NASDAQ OMX
Silvia Davi
646-441-5014
silvia.davi@nasdaq.com
Robert Madden
646-441-5045
Robert.Madden@NASDAQOMX.COM
Copyright © 2009 GlobeNewswire. All rights reserved. Redistribution of this content is expressly prohibited without prior written consent. GlobeNewswire makes no claims concerning the accuracy or validity of the information, and shall not be held liable for any errors, delays, omissions or use thereof.